Page not found | Columbia University Medical Center -->


 
















      Professor of Medicine

      Division of Preventive Medicine and Nutrition
      Columbia University College of Physicians and Surgeons
      P & S 9-513
      630 West 168th Street
      New York, NY 10032
      Ph. 212-305-5961
      Fax: 212-305-5384
      Email: ijg3@columbia.edu

1971B.S. - Massachusetts Institute of Technology
1975M.D. - Harvard Medical School
1975-1976Internship - New York University-Bellevue Hospital Medical Center, New York, NY
1976-1978Residency - Jr. & Sr. Resident in Medicine, New York University-Bellevue Hospital Medical Center, New York, NY
1978-1979Fellowship - Endocrinology & Metabolism, Mount Sinai School of Medicine, New York, NY
1979-1981Fellowship - Arteriosclerosis and Metabolism, Mount Sinai School of Medicine, New York, NY
1981-1983Instructor in Medicine, Mount Sinai School of Medicine, New York, NY
1983-1990Assistant Professor of Medicine, Columbia University College of Physicians & Surgeons, New York, NY
1990-1996Associate Professor of Medicine, Columbia University College of Physicians & Surgeons, New York, NY
1995Acting Director (During Director's Sabbatical Leave), Institute of Human Nutrition, Columbia University, New York, NY
1996Professor of Medicine, Columbia University College of Physicians & Surgeons, New York, NY
1983-1990Assistant Attending Physician, Department of Medicine, Columbia-Presbyterian Medical Center, New York, NY
1985-PresentAssociate Director, Arteriosclerosis Research Center, Columbia-Presbyterian Medical Center, New York, NY
1990-1996Associate Attending Physician, Department of Medicine, Columbia-Presbyterian Medical Center, New York, NY
1996-PresentAttending Physician, Department of Medicine, Columbia-Presbyterian Medical Center, New York, NY
1981-1986Clinician-Scientist Award, American Heart Association
1988-1993Established Fellowship, New York Heart Association
1991American Society for Clinical Investigation - elected 1991
1992University Tenure, Columbia University
1999Association of American Physicians, elected 1999
Session Chairman, American Heart Association Annual Scientific Sessions, 1988,1990,1991,1993,1995,1996,1997,1998
Association of American Physicians
American Society for Clinical Investigation
American Heart Association
Fellow, Council on Arteriosclerosis
Nominating and membership committees, 1994-1995
Abstract grading Committee, 1995
Nutrition Committee, 1997
Committee for Scientific Sessions Program, 1997-2000
American Heart Association - New York City Affiliate
Chairman, Committee on Cholesterol Education, 1988-1992
Member - Community Programs, 1988-1990
Professioal Education Committee, 1988-1992
Peer review committee, 1993-1994., Co-chairman 1994-1995, Chairman 1995-1997
Board of Directors (term 1993-1999)
American Heart Association, Heritage Affiliate
Board of Directors, 1998-2000
Chair, Research Council, 1998-2000
New York Diabetes Association
Chairman of the Clinical Society, 1988-1989
Symposium Committee, Chairman, 1987
Clinic Advisory Committee, Chairman, 1985-1987
American Federation for Clinical Research
American College of Physicians
American Association for the Advancement of Science
New York Lipid Club, President, 1992-1993

      Aetna
      Anthem
      Blue Choice PPO
      Blue Cross Prestige
      Blue Cross Senior
      Cambridge
      CIGNA
      CIGNA POS
      Comm Premier Plus
      HIP
      Managed Care Inc
      Medichoice
      NPPN
      Oxford Commercial
      Oxford POS
      PHCS
      Prudential

NewYork-Presbyterian Hospital

Endocrinology
Diabetes and Metabolism
Internal Medicine

Merkel, M., Y.S. Kako, H. Radner, I.S. Cho, R. Ramasamy, J.D. Brunzell, I.J. Goldberg and J.L. Breslow, Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases VLDL uptake. Direct evidence that LPL bridging occurs in vivo., Proc Natl Acad Sci USA, 95:13841-13846, 1998

Goldberg, I.J., W.D. Wagner, L. Pang, L. Paka, L.K. Curtiss, J.A. DeLozier, G.A Shelness, C.S.H. Young and S. Pillarisetti, Evidence that the amino-terminal region is sufficient for lipoprotein interaction with proteoglycans., J Biol Chem, 273:35355-35361, 1998

Van Bennekum, A.M., Y. Kako, P.H. Weinstock, E.H. Harrison, R.J. Deckelbaum, I.J. Goldberg and W.S. Blaner, Lipoprotein lipase expression influences tissue clearance of chylomicron retinyl ester., J. Lipid Res, 40:565-574, 1999

Balagopalakrishna, C., L. Paka, S. Pillarisetti and I.J. Goldberg, Lipolysis-induced-iron release from diferric transferrin: possible role of lipoprotein lipase in LDL oxidation., J. Lipid Res, 40:1347-1356, 1999

Nielsen, L.B., M. Sullivan, T. Vanni-Reyes, I.J. Goldberg and S.G. Young, Transgenic mouse expression studies reveal that the DNA sequences required for apolipoprotein B expression in the heart are distinct from those required in the intestine., Mol Cell Cardio, 4:695-703, 1999

Kako, Y., L-S Huang, J. Yang, T. Katopodis, R. Ramakrishnan, I.J. Goldberg, Streptozotocin-induced diabetes in human apoB transgenic mice: Effects on lipoproteins and atherosclerosis., J. Lipid Res, 40:2185-2194, 1999

Paka, L., J.O. Obunike, S.Y. Choi, I.J. Goldberg, S. Pillarisetti, Identification of perlecan as a key autocrine regulator of smooth muscle cell growth., J. Biol Chem, 274:36403-36408,1999

Obunike, J.C., S. Pillarisetti, L. Paka, Y. Ho, M. Butteri, N. Yamada, T. Mazzone, R.J. Deckelbaum, I.J. Goldberg, Heparin-binding proteins apoE and lipoprotein lipase increase proteoglycan production by cells., Arterio Thromb Vasc Biol, 20:111-118, 2000

Goldberg, I.J., T. Vanni-Reyes, S. Ramakrishnon, S. Hollaran, H.N. Ginsberg., Body mass index modified the effects of lipoprotein lipase on plasma lipoproteins., J Cardiovascular Risk, 7:31-38, 2000

Rutledge, J.C., A.E. Mullick, G. Gardiner, I.J. Goldberg, VLDL provides and HDL removes lipids from the arterial wall: Direct visualization of lipid deposition and reverse lipid transport in a perfused artery., Circ Research, accepted for publication

HOME



Updated: June 13, 2000